Akèy › Maladi selil fòs › Texas › Houston
Etid klinik pou Maladi selil fòs nan Houston, TX
10 etid pou Maladi selil fòs ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
A Study to Investigate the Efficacy and Safety of Crizanlizumab (5 mg/kg) Compared With Placebo in Adolescent and Adult Sickle Cell Disease Patients Who Experience Frequent Vaso-Occlusive Crises (SPARKLE)
Ap rekriteFaz 3
- Texas Childrens Cancer and Hematology Center, Houston
- U of TX Health Science Ct, Houston
A Research Study Looking at Long-term Treatment With Etavopivat in People With Sickle Cell Disease or Thalassaemia
Ap rekriteFaz 3
- Texas Children's Hospital_Houston, Houston
- UT Health University of Texas, Houston
A Study to Evaluate How Well Etavopivat Works in People With Sickle Cell Disease
Ap rekriteFaz 3
- UT Health University of Texas, Houston
A Phase I/II Study of ITU512 in Healthy Participants and Patients With Sickle Cell Disease
Ap rekriteFaz 1/2Volontè an sante akeyi
- UT Health Science Center, Houston
ATHN Transcends: A Natural History Study of Non-Neoplastic Hematologic Disorders
Ap rekriteEtid obsèvasyon
- Gulf States Hemophilia and Thrombophilia Center, Houston
- Texas Children's Hemophilia & Thrombosis Center/Baylor College of Medicine, Houston
The Efficacy and Safety of Rilzabrutinib in Participants Aged 10 to 65 Years With Sickle-cell Disease
Ap rekriteFaz 3
- Baylor College of Medicine- Site Number : 8400055, Houston
Comparing the Effectiveness of Matched Related Donor Hematopoietic Stem Cell Transplantation to Disease Modifying Therapy in Pediatric Patients With Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- Texas Children's Hopsital (NT-DMT), Houston
- Texas Children's Hospital (MRD-HCT), Houston
Study of a Single Dose of a 21-valent Pneumococcal Conjugate Vaccine in Children and Adolescents With Sickle Cell Disease
Ap rekriteFaz 3
- Site # 8400004, Houston
Zinc Supplementation in Sickle Cell Disease: A Precursor to the Think Zinc for Bones Trial
Ap rekriteFaz 2
- Baylor College of Medicine, Houston
Recruitment and Engagement in Care to Impact Practice Enhancement (RECIPE) for Sickle Cell Disease
Ap rekriteEtid obsèvasyon
- University of Texas at Houston, Houston
Etid Maladi selil fòs nan lòt vil
- Atlanta, GA22 etid
- Washington, DC20 etid
- Memphis, TN18 etid
- Chicago, IL18 etid
- Philadelphia, PA15 etid
- Birmingham, AL14 etid
- New York City, NY13 etid
- St. Louis, MO12 etid
- Durham, NC10 etid
- Cincinnati, OH10 etid
- Boston, MA10 etid
- Pittsburgh, PA9 etid
Lòt etid nan Houston
- Kansè Poumon ki pa ti selil145 etid
- Kansè nan tete126 etid
- Kansè (tout kalite)121 etid
- Kansè Metastatik104 etid
- Kansè kolorektal102 etid
- Kansè ovè89 etid
- Leksemi mieloïd egi85 etid
- Kansè poumon78 etid
- Kansè pwostat76 etid
- Kansè Endomèt68 etid
- Kansè pankreyas61 etid
- Melanom59 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.